Intuniv and Generalized anxiety disorder - a phase IV clinical study of FDA data


Generalized anxiety disorder is reported only by a few people who take Intuniv.

The phase IV clinical study analyzes which people take Intuniv and have Generalized anxiety disorder. It is created by eHealthMe based on reports of 2,980 people who have side effects while taking Intuniv from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

2,980 people reported to have side effects when taking Intuniv.
Among them, 2 people (0.07%) have Generalized anxiety disorder.

What is Intuniv?

Intuniv has active ingredients of guanfacine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 3,440 Intuniv users for its effectiveness, alternative drugs and more.

What is Generalized anxiety disorder?

Generalized anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry) is found to be associated with 1,805 drugs and 1,384 conditions by eHealthMe.

Number of Intuniv and Generalized anxiety disorder reports submitted per year:

Could Intuniv cause Generalized anxiety disorder?

Gender of people who have Generalized anxiety disorder when taking Intuniv *:

  • female: 50 %
  • male: 50 %

Age of people who have Generalized anxiety disorder when taking Intuniv *:

  • 0-1: 0.0 %
  • 2-9: 100 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Intuniv *:

  1. Zoloft: 1 person, 50.00%
  2. Vyvanse: 1 person, 50.00%
  3. Focalin Xr: 1 person, 50.00%

Common side effects people have besides Generalized anxiety disorder *:

  1. Suicidal Ideation: 1 person, 50.00%
  2. Suicidal Behavior: 1 person, 50.00%
  3. Psychotic Disorder: 1 person, 50.00%
  4. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 1 person, 50.00%
  5. Oppositional Defiant Disorder (a childhood disorder described by the diagnostic and statistical manual of mental disorders): 1 person, 50.00%
  6. Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 1 person, 50.00%
  7. Insomnia (sleeplessness): 1 person, 50.00%
  8. Disturbance In Social Behavior: 1 person, 50.00%
  9. Depression: 1 person, 50.00%
  10. Alopecia Areata (patchy baldness that typically begins with rapid hair loss): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Intuniv and have Generalized anxiety disorder?

Check whether Generalized anxiety disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Generalized anxiety disorder and when was it recovered:

Expand to all the drugs that have ingredients of guanfacine hydrochloride:

Alternative drugs to, pros and cons of Intuniv:

Common Intuniv side effects:

Browse all side effects of Intuniv:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Generalized anxiety disorder treatments and more:

COVID vaccines that are related to Generalized anxiety disorder:

Common drugs associated with Generalized anxiety disorder:

All the drugs that are associated with Generalized anxiety disorder:

Common conditions associated with Generalized anxiety disorder:

All the conditions that are associated with Generalized anxiety disorder:

How the study uses the data?

The study uses data from the FDA. It is based on guanfacine hydrochloride (the active ingredients of Intuniv) and Intuniv (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: